美国 · 综合新闻 · The Boston Globe
Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives
The FDA officially warned patients not to use compounded GLP-1s this month unless an individual’s medical needs cannot be met by approved name-brand drugs.
在 The Boston Globe 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.bostonglobe.com)




